All Work

Chris Lange

Will Wendy’s Choke on Its New Breakfast Expansion?

Wendy’s is moving back into breakfast with its most recent business update. The burger chain announced that it plans to launch its breakfast menu, currently available in more than 300 restaurants, across the U.S.…

Chris Lange · 7 years ago

Why Francesca’s Is Tuesday’s Top Retailer

Francesca’s may not be a household name like Walmart, Target or other major retailers. However, its shares were absolutely beating every other retailer in the market early Tuesday.

Chris Lange · 7 years ago

Amgen’s Lung Cancer Study Needs to Take a Breather

Amgen shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data is coming from the ongoing Phase 1 study evaluating AMG 510 in patients with…

Chris Lange · 7 years ago

Sohu Moves to Acquire Changyou

Changeyou.com shares made a massive gain on Monday after the firm said that it had received an acquisition offer from Sohu.com.

Chris Lange · 7 years ago

Why This New Dementia Study Is a Huge Hit

Acadia Pharmaceuticals shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint.

Chris Lange · 7 years ago

New Cellulite Study Submission Could Be a Big Hit

Endo shares jumped on Friday after the company announced that it has submitted a Biologics License Application to the FDA for collagenase clostridium histolyticum for the treatment of cellulite in the buttocks.

Chris Lange · 7 years ago

Why Analysts Are Growing More Optimistic on Lululemon

So far Lululemon has been on a tear in 2019, with shares up about 55%, and after its earnings report it doesn’t seem like the stock will stop anytime soon. Analysts were quick to…

Chris Lange · 7 years ago

Lululemon Stretches Earnings in Q2

Lululemon released better than expected fiscal second-quarter financial results after the markets closed on Thursday.

Chris Lange · 7 years ago

Why This Analyst Sees Cidara Nearly Doubling

While just announced huge deal seems to be the big break that Cidara Therapeutics needs, one analyst believes this stock could nearly double in the next 12 months.

Chris Lange · 7 years ago

Signet Jewelers Shines in Q2

Signet Jewelers released better than expected fiscal second-quarter financial results before the markets opened on Thursday.

Chris Lange · 7 years ago

Palo Alto Networks Slips Up in Q4

Palo Alto Networks reported better than expected fiscal fourth-quarter financial results after the markets closed on Wednesday.

Chris Lange · 7 years ago